31,074 Kenvue Inc. $KVUE Shares Bought by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. raised its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 9.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 348,133 shares of the company’s stock after purchasing an additional 31,074 shares during the quarter. Rakuten Investment Management Inc.’s holdings in Kenvue were worth $6,235,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. BlackRock Inc. bought a new stake in shares of Kenvue in the 2nd quarter worth about $2,882,279,000. Pentwater Capital Management LP purchased a new stake in shares of Kenvue during the 2nd quarter valued at about $977,094,000. HBK Investments L P lifted its holdings in shares of Kenvue by 33.3% in the 2nd quarter. HBK Investments L P now owns 28,000,001 shares of the company’s stock valued at $535,080,000 after acquiring an additional 7,000,000 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Kenvue by 0.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 22,270,175 shares of the company’s stock valued at $383,938,000 after acquiring an additional 196,981 shares during the last quarter. Finally, Amundi lifted its holdings in shares of Kenvue by 41.2% in the 2nd quarter. Amundi now owns 18,483,326 shares of the company’s stock valued at $353,216,000 after acquiring an additional 5,392,413 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Stock Performance

KVUE stock opened at $19.31 on Friday. Kenvue Inc. has a twelve month low of $14.06 and a twelve month high of $20.13. The stock has a market capitalization of $37.09 billion, a price-to-earnings ratio of 21.94, a price-to-earnings-growth ratio of 1.77 and a beta of 0.48. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67. The firm’s fifty day simple moving average is $18.41 and its two-hundred day simple moving average is $18.23.

Kenvue (NYSE:KVUE) last released its earnings results on Friday, October 30th. The company reported $0.29 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.29. The firm had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.86 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The business’s revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the business earned $0.28 EPS. As a group, analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 2nd. Investors of record on Monday, September 21st were issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 4.4%. The ex-dividend date was Monday, September 21st. Kenvue’s dividend payout ratio is presently 95.45%.

Wall Street Analyst Weigh In

KVUE has been the subject of several recent research reports. Barclays lifted their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. Wall Street Zen downgraded Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. UBS Group raised their price objective on Kenvue from $19.00 to $20.00 and gave the company a “neutral” rating in a research note on Monday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Kenvue in a research note on Friday, September 11th. Finally, HSBC dropped their target price on Kenvue from $20.00 to $19.00 and set a “hold” rating for the company in a report on Monday, August 10th. Ten analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $19.29.

About Kenvue

Kenvue Inc is a consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, and essential health products, serving consumers through retail, e-commerce and other distribution channels.

The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; and Listerine, Johnson’s and OGX in oral care, baby care and hair care.